← SynDRA
FOROPAFANT
SynDRA canonical compound SYN0025809 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PTAFR |
|---|
| Mechanism of action | platelet activating factor receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- PTAFR ANTAGONIST
- platelet activating factor receptor antagonist
Drug classes
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- SR-27417
- 2-[N-[2-(Dimethylamino)ethyl]-N-(3-pyridylmethyl)amino]-4-(2,4,6-triisopropylphenyl)thiazole
- SR 27417
- VWJ2QVH41J
- SR27417A
- foropafantum
- RefChem:141328
- DTXCID70817763
- Foropafant [INN]
- SR27417
- C28H40N4S
- UNII-VWJ2QVH41J
- MLS006010675
- GTPL1856
- orb1308292
- SCHEMBL7156608
- SCHEMBL29850589
- HMS3755K09
- AKOS016007386
- CS-W011545
- MS-28563
- SMR004701657
- DB-063146
- HY-128694
- NS00126147
- F85608
- SR 27417, >=98% (HPLC)
- T15338
- L001072
- SR-01000945037
- SR-01000945037-1
- BRD-K57774929-001-01-3
- 9ER
- SR-27417A
- orb1738619
- Foropafant fumarate
- UNII-77229931IM
Look up FOROPAFANT in the interactive SynDRA portal →